BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 10118461)

  • 1. Delegations of authority and organization; issuance of written notices--FDA. Final rule.
    Fed Regist; 1992 May; 57(85):18823-4. PubMed ID: 10118461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
    Fed Regist; 1994 Jun; 59(116):31138. PubMed ID: 10136908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delegations of authority and organization; Center for Drug Evaluation and Research--FDA. Final rule.
    Fed Regist; 1993 Apr; 58(61):17093-4. PubMed ID: 10125229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delegations of authority and organization; Ryan White Comprehensive AIDS Resources Emergency Act of 1990--FDA. Final rule.
    Fed Regist; 1991 Aug; 56(167):42527. PubMed ID: 10113840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Food and Drug Administration--Delegations of authority and organization, health information and health promotion programs. Final rule.
    Fed Regist; 1980 Apr; 45(82):27924-5. PubMed ID: 10246087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delegations of authority and organization; Center for Devices and Radiological Health. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Feb; 64(21):4964-5. PubMed ID: 10557613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delegations of authority and organization; National Childhood Vaccine Injury Act of 1986--FDA. Final rule.
    Fed Regist; 1993 Apr; 58(61):17105-6. PubMed ID: 10125232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delegations of authority and organization--FDA. Final rule.
    Fed Regist; 1998 Apr; 63(72):18314-7. PubMed ID: 10179312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delegations of authority and organization; Office of the Commissioner--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58758. PubMed ID: 10115698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule.
    Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
    Fed Regist; 1998 May; 63(95):27207-8. PubMed ID: 10179344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delegations of authority and organization; Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, and Center for Drug Evaluation and Research--FDA. Final rule.
    Fed Regist; 1991 Nov; 56(225):58758-9. PubMed ID: 10115699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule.
    Fed Regist; 1991 Oct; 56(197):51169-70. PubMed ID: 10115059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delegations of authority and organization; new drug applications--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Jun; 47(120):26822-3. PubMed ID: 10255868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan; 65(1):7-9. PubMed ID: 11010625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug labeling; sodium labeling for over-the-counter drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2004 Nov; 69(228):69278-80. PubMed ID: 15570675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissemination of information on unapproved/new uses for marketed drugs, biologics, and devices--FDA. Final rule.
    Fed Regist; 1998 Nov; 63(224):64556-88. PubMed ID: 10339052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delegations of authority and organization--FDA. Final rule.
    Fed Regist; 1993 Apr; 58(61):17091-3. PubMed ID: 10125228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.